Saggita® is a nano-platform, discovered by RS Research, that can deliver medication to targeted places in the human body. The platform is like a tiny postman that uses several nano-technologies. A nano-platform can be linked to a variety of active substances, small molecules or antibodies. With these platforms, it’s possible to administer high dosages of medication in a very targeted way, without severe side-effects. This technique would be especially significant for treating different kinds of cancer. Chemotherapies also destroy healthy cells, which leads to unpleasant side-effects. It would thus be a tremendous improvement in the patient’s experience if the therapy is more specifically targeted at malignant
cells. Clinical testing for the treatment of different types of cancer will start in the autumn of 2020.
